Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01330628 · ClinicalTrials.gov registry record · Phase 2

Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis

A Phase 2 study, sponsored by Spectranetics Corporation.

Completed
Registry status
Phase 2
Development phase
252
Enrollment target

NCT01330628: Completed Phase 2 study, sponsored by Spectranetics Corporation.

NCT01330628 is a Phase 2 study that has completed, run by Spectranetics Corporation. The registered enrollment target is 252 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01330628, a Phase 2 study, has completed, sponsored by Spectranetics Corporation.

COMPLETED
Registry status
Phase 2
Development phase
252 participants
Enrollment target

Study Summary

The purpose of the study is to evaluate the safety and efficacy of laser atherectomy with balloon angioplasty compared to balloon angioplasty alone in the treatment of above the knee peripheral artery in-stent restenosis.

Primary Outcome

Number of participants free from Target Lesion Revascularization (TLR) through 6 months follow-up.

Interventions

  • DEVICE Turbo Elite Laser and Turbo Tandem Laser Guide Catheters
  • PROCEDURE Balloon angioplasty

Trial Details

FieldValue
Enrollment Target 252 participants
Start Date 2011-06
Est. Completion 2015-05
Phase Phase 2
Spectranetics Corporation

6 total trials

What the finished NCT01330628 record still lists

NCT01330628 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% higher).

The record links to 0 conditions, and to 2 interventions - of which Turbo Elite Laser and Turbo Tandem Laser Guide Catheters is the first listed.

NCT01330628 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01330628 about?

NCT01330628 is a clinical study titled "Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis". The purpose of the study is to evaluate the safety and efficacy of laser atherectomy with balloon angioplasty compared to balloon angioplasty alone in the treatment of above the knee peripheral artery in-stent restenosis.

What is the current status of trial NCT01330628?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 252 participants. The study started on 2011-06. Estimated completion is 2015-05.

What interventions are being tested in trial NCT01330628?

The interventions under investigation include: Turbo Elite Laser and Turbo Tandem Laser Guide Catheters (DEVICE), Balloon angioplasty (PROCEDURE).

Who is sponsoring clinical trial NCT01330628?

This trial is sponsored by Spectranetics Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01330628's enrollment target sits among peer trials

252 220th of 2000 higher than 1,779 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02314988 · 252 participants · Phase 2

    Tranexamic Acid to Reduce Blood Loss in Spine Surgery

  • NCT03941756 · 252 participants · NA

    Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma

  • NCT05219617 · 252 participants · Phase 3

    Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  • NCT05384158 · 252 participants · NA

    Valuation in Depressed Mood, Anhedonia, and Anxiety

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01330628, the US trial registry maintained by the National Library of Medicine. NCT01330628 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.